Balance Sheet

Cash Flow Statement

Acquisitions Amortization of Deferred Charges Amortization of Deferred Charges Amortization of Goodwill Amortization of Goodwill Amortizatization of Intangibles Amortizatization of Intangibles Asset Writedowns and Impairment Asset Writedowns and Impairment Capital Expenditures Capital Expenditures Cash from Financing Activities Cash from Financing Activities Cash from Investing Activities Cash from Investing Activities Cash from Operations Cash from Operations Cash from Restructuring Change in Account Payables Change in Account Payables Change in Accured Expenses Change in Accured Expenses Change in Acquisitions & Divestments Change in Acquisitions & Divestments Change in Cash Change in Intangibles Change in Intangibles Change in Inventory Change in Inventory Change in Receivables Change in Receivables Change in Taxes Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and Depletion Depreciation and Depletion Divestments Exchange Rate Effect Exchange Rate Effect Free Cash Flow Free Cash Flow Gains from Investment Securities Gains from Investment Securities Gains from Sales and Divestitures Gains from Sales and Divestitures Long-Term Debt Issuances Long-Term Debt Repayments Net Cash Flow Net Cash Flow Net Income Non-cash Items Non-cash Items Other Working Capital Changes Other Working Capital Changes Other financing activities Other financing activities Sales of Property, Plant and Equipment Sales of Property, Plant and Equipment Share-based Compensation Share-based Compensation Shares Issued Shares Repurchased Short-Term Debt issuances Short-Term Debt repayments

Daily Values

Growth Metrics

Harvard Bioscience (HBIO) Shares Issued (2016 - 2025)

Harvard Bioscience (HBIO) has disclosed Shares Issued for 16 consecutive years, with $1000.0 as the latest value for Q4 2025.

Quarterly Shares Issued fell 99.38% to $1000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $47000.0 through Dec 2025, down 87.63% year-over-year, with the annual reading at $47000.0 for FY2025, 87.63% down from the prior year.
Shares Issued for Q4 2025 was $1000.0 at Harvard Bioscience, down from $46000.0 in the prior quarter.
The five-year high for Shares Issued was $1.9 million in Q1 2021, with the low at $1000.0 in Q4 2025.
Average Shares Issued over 5 years is $308705.9, with a median of $161000.0 recorded in 2024.
The sharpest move saw Shares Issued skyrocketed 2042.86% in 2021, then crashed 99.38% in 2025.
Over 5 years, Shares Issued stood at $405000.0 in 2021, then crashed by 42.96% to $231000.0 in 2022, then decreased by 10.82% to $206000.0 in 2023, then decreased by 21.84% to $161000.0 in 2024, then plummeted by 99.38% to $1000.0 in 2025.
According to Business Quant data, Shares Issued over the past three periods came in at $1000.0, $46000.0, and $161000.0 for Q4 2025, Q2 2025, and Q4 2024 respectively.